A Clinical Study to Assess Safety and Efficacy of a Tumor Vaccine in Patients With Advanced Renal Cell Carcinoma (ASET)

Clinical trial NCT01265368 · COMPLETED

Trial details

NCT number: NCT01265368
Sponsor: Mologen AG
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IV Renal Cell Cancer

Start date: 2010-11-01
Primary completion: 2013-08-01
Enrollment: 19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.